155 related articles for article (PubMed ID: 12730015)
1. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells.
Liao KW; Hung SW; Hsiao YW; Bennett M; Chu RM
Vet Immunol Immunopathol; 2003 May; 92(3-4):149-62. PubMed ID: 12730015
[TBL] [Abstract][Full Text] [Related]
2. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.
Hsiao YW; Liao KW; Hung SW; Chu RM
Vet Immunol Immunopathol; 2002 Aug; 87(1-2):19-27. PubMed ID: 12052339
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of the local inflammatory infiltrate in spontaneous canine transmissible venereal tumour at different stages of growth.
Pérez J; Day MJ; Mozos E
Vet Immunol Immunopathol; 1998 Jul; 64(2):133-47. PubMed ID: 9661263
[TBL] [Abstract][Full Text] [Related]
4. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
[TBL] [Abstract][Full Text] [Related]
5. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT?
do Prado Duzanski A; Flórez LMM; Fêo HB; Romagnoli GG; Kaneno R; Rocha NS
Res Vet Sci; 2022 Jul; 145():193-204. PubMed ID: 35240476
[TBL] [Abstract][Full Text] [Related]
7. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor.
Liu CC; Wang YS; Lin CY; Chuang TF; Liao KW; Chi KH; Chen MF; Chiang HC; Chu RM
Cancer Immunol Immunother; 2008 Apr; 57(4):479-91. PubMed ID: 17710396
[TBL] [Abstract][Full Text] [Related]
8. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
9. Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid.
Pai CC; Kuo TF; Mao SJ; Chuang TF; Lin CS; Chu RM
Vet Immunol Immunopathol; 2011 Feb; 139(2-4):187-99. PubMed ID: 21051091
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta 1 and restores the lymphokine-activated killing activity.
Hsiao YW; Liao KW; Hung SW; Chu RM
J Immunol; 2004 Feb; 172(3):1508-14. PubMed ID: 14734728
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for the treatment of canine transmissible venereal tumor based in dendritic cells pulsed with tumoral exosomes.
Ramos-Zayas Y; Franco-Molina MA; Hernádez-Granados AJ; Zárate-Triviño DG; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Ramírez-Romero R; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):48-54. PubMed ID: 30334465
[No Abstract] [Full Text] [Related]
12. Lack of MHC expression and retention of ultrastructural characteristics by xenograft transmissible venereal tumor cells in SCID mice.
Harmelin A; Pinthus JH; Friedmann-Morvinski D; Kaufman K; Brenner O
Vet Immunol Immunopathol; 2002 Jul; 86(3-4):245-9. PubMed ID: 12007890
[TBL] [Abstract][Full Text] [Related]
13. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.
Hsiao YW; Liao KW; Chung TF; Liu CH; Hsu CD; Chu RM
Cancer Immunol Immunother; 2008 Jul; 57(7):1091-104. PubMed ID: 18259750
[TBL] [Abstract][Full Text] [Related]
14. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
Mukaratirwa S; Gruys E
Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
[TBL] [Abstract][Full Text] [Related]
15. Computerized Cytomorphometric and Cytomorphological Analysis of Canine Transmissible Venereal Tumours.
Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
J Comp Pathol; 2018 Aug; 163():18-22. PubMed ID: 30213369
[TBL] [Abstract][Full Text] [Related]
16. In vitro cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity to the transmissible venereal tumor of the dog.
Cohen D
J Natl Cancer Inst; 1980 Feb; 64(2):317-21. PubMed ID: 6928223
[TBL] [Abstract][Full Text] [Related]
17. Use of a murine xenograft model for canine transmissible venereal tumor.
Harmelin A; Pinthus JH; Katzir N; Kapon A; Volcani Y; Amariglio EN; Rehavi G
Am J Vet Res; 2001 Jun; 62(6):907-11. PubMed ID: 11400849
[TBL] [Abstract][Full Text] [Related]
18. Extensive conservation of genomic imbalances in canine transmissible venereal tumors (CTVT) detected by microarray-based CGH analysis.
Thomas R; Rebbeck C; Leroi AM; Burt A; Breen M
Chromosome Res; 2009; 17(7):927-34. PubMed ID: 19798471
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characterization of canine transmissible venereal tumor.
Mozos E; Méndez A; Gómez-Villamandos JC; Martín De Las Mulas J; Pérez J
Vet Pathol; 1996 May; 33(3):257-63. PubMed ID: 8740698
[TBL] [Abstract][Full Text] [Related]
20. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
